Business Description
Inno-Gene SA
NAICS : 622110
SIC : 8062
ISIN : PLINNGN00015
Description
Inno-Gene SA operates a DNA research facility that deals with genetic diagnostics, research and development. The company provides services in the field of genetic medical diagnosis, including diagnosis of microbial infections and innate predispositions.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.8 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.07 | |||||
| Beneish M-Score | -9.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -37.2 | |||||
| 3-Year FCF Growth Rate | -210.9 | |||||
| 3-Year Book Growth Rate | 7.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.55 | |||||
| 9-Day RSI | 30.72 | |||||
| 14-Day RSI | 37.49 | |||||
| 6-1 Month Momentum % | 107.14 | |||||
| 12-1 Month Momentum % | 24.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | |||||
| Quick Ratio | 1.19 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 184.98 | |||||
| Days Sales Outstanding | 577.81 | |||||
| Days Payable | 161.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.49 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -44.13 | |||||
| Operating Margin % | -634.78 | |||||
| Net Margin % | -1325 | |||||
| FCF Margin % | -129.13 | |||||
| ROE % | -118.15 | |||||
| ROA % | -77.94 | |||||
| ROIC % | -48.72 | |||||
| ROC (Joel Greenblatt) % | -671.48 | |||||
| ROCE % | -100.14 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 418.14 | |||||
| PS Ratio | 37.83 | |||||
| PB Ratio | 6.51 | |||||
| Price-to-Tangible-Book | 6.56 | |||||
| EV-to-EBIT | -3.39 | |||||
| EV-to-EBITDA | -3.44 | |||||
| EV-to-Revenue | 39.2 | |||||
| EV-to-FCF | -36.62 | |||||
| Price-to-Projected-FCF | 1.23 | |||||
| Price-to-Median-PS-Value | 6.7 | |||||
| Price-to-Net-Current-Asset-Value | 59 | |||||
| Earnings Yield (Greenblatt) % | -29.64 | |||||
| FCF Yield % | -3.23 | |||||
| Forward Rate of Return (Yacktman) % | 29.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inno-Gene SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 0.46 | ||
| EPS (TTM) (zł) | -1.062 | ||
| Beta | -1.07 | ||
| Volatility % | 136.06 | ||
| 14-Day RSI | 37.49 | ||
| 14-Day ATR (zł) | 0.271696 | ||
| 20-Day SMA (zł) | 3.431 | ||
| 12-1 Month Momentum % | 24.01 | ||
| 52-Week Range (zł) | 1.65 - 5.6 | ||
| Shares Outstanding (Mil) | 6.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inno-Gene SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inno-Gene SA Stock Events
| Event | Date | Price(zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inno-Gene SA Frequently Asked Questions
What is Inno-Gene SA(WAR:IGN)'s stock price today?
The current price of WAR:IGN is zł2.95. The 52 week high of WAR:IGN is zł5.60 and 52 week low is zł1.65.
When is next earnings date of Inno-Gene SA(WAR:IGN)?
The next earnings date of Inno-Gene SA(WAR:IGN) is .
Does Inno-Gene SA(WAR:IGN) pay dividends? If so, how much?
Inno-Gene SA(WAR:IGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers